Susquehanna International Group’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.2M | Sell |
|
|||||
|
2025
Q2 | $3.94M | Sell |
|
|||||
|
2025
Q1 | $9.3M | Buy |
|
|||||
|
2024
Q4 | $2.7M | Buy |
|
|||||
|
2024
Q3 | $1.82M | Sell |
|
|||||
|
2024
Q2 | $12.3M | Buy |
|
|||||
|
2024
Q1 | $2.08M | Sell |
|
|||||
|
2023
Q4 | $2.52M | Buy |
|
|||||
|
2023
Q3 | $955K | Buy |
|
|||||
|
2023
Q2 | $441K | Sell |
|
|||||
|
2023
Q1 | $2.85M | Buy |
|
|||||
|
2022
Q4 | $731K | Sell |
|
|||||
|
2022
Q3 | $1.24M | Buy |
|
|||||
|
2022
Q2 | $516K | Buy |
|
|||||
|
2022
Q1 | $1.2M | Sell |
|
|||||
|
2021
Q4 | $10.1M | Buy |
|
|||||
|
2021
Q3 | $4.74M | Buy |
|
|||||
|
2021
Q2 | $957K | Sell |
|
|||||
|
2021
Q1 | $884K | Buy |
|
|||||
|
2020
Q4 | $410K | Buy |
|
|||||
|
2020
Q3 | $219K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $601K | Buy |
|
|||||
|
2018
Q4 | $102K | Buy |
|